UnitedHealth Group Incorporated UNH
376.59
1.58
0.42%
as of 25 Sep
- Market cap
- $336.8B
- P/E
- 24.2×
Follow UNH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
UnitedHealth Group Incorporated (UNH) P/E ratio
As of 25 September 2026, UnitedHealth Group Incorporated (UNH) trades at a P/E ratio of 24.2×. Over the past ten years it has ranged from 10.3× (August 2025) to 40.7× (November 2024); the current reading is higher than 74% of that period. That is in line with the Healthcare Plans industry median of 23.8× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 25.0× | (23.31%) |
| FY2024 | 32.6× | 44.26% |
| FY2023 | 22.6× | (7.57%) |
| FY2022 | 24.5× | (11.87%) |
| FY2021 | 27.8× | 26.95% |
| FY2020 | 21.9× | 6.64% |
| FY2019 | 20.5× | 0.38% |
| FY2018 | 20.4× | (1.03%) |
| FY2017 | 20.6× | (4.46%) |
| FY2016 | 21.6× | 10.42% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 26.7× | 30.87% |
| Mar 2026 | 20.4× | (18.34%) |
| Dec 2025 | 25.0× | 38.87% |
| Sep 2025 | 18.0× | 33.33% |
| 42 more quarters | Free account |
Against its own ten years
Low 10.3×
High 40.7×
Ten-year median
21.8×
Current reading's percentile
74
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CLOV Clover Health Investments, Corp. compare | n/m |
| MOH Molina Healthcare, Inc compare | n/m |
| CNC Centene Corporation compare | n/m |
| CI Cigna Group compare | 11.3× |
| OSCR Oscar Health, Inc. compare | 17.3× |
| ELV Elevance Health, Inc. compare | 17.6× |
| CVS CVS Health Corporation compare | 23.3× |
| UNH UnitedHealth Group Incorporated | 24.2× |
| HUM Humana Inc. compare | 37.4× |
| Healthcare Plans industry median | 23.8× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on UNH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement